6-tert-butyl-4-hydroxy-2H-pyran-2-one
|
- $178 - $889
- Product name: 6-tert-butyl-4-hydroxy-2H-pyran-2-one
- CAS: 857248-84-1
- MF: C9H12O3
- MW: 168.19
- EINECS:
- MDL Number:MFCD06762852
- Synonyms:6-tert-butyl-4-hydroxy-2H-pyran-2-one;2H-Pyran-2-one, 6-(1,1-dimethylethyl)-4-hydroxy-;6-(1,1-Dimethylethyl)-4-hydroxy-2H-pyran-2-one
4 prices
Selected condition：
Brand
- American Custom Chemicals Corporation
- Chemenu
Package
- 5MG
- 100mg
- 250mg
- 1g
- ManufacturerAmerican Custom Chemicals Corporation
- Product numberCHM1554885
- Product description6-TERT-BUTYL-4-HYDROXY-PYRAN-2-ONE 95.00%
- Packaging5MG
- Price$455.86
- Updated2021-12-16
- Buy
- ManufacturerChemenu
- Product numberCM325813
- Product description6-tert-butyl-4-hydroxy-pyran-2-one 95+%
- Packaging100mg
- Price$178
- Updated2021-12-16
- Buy
- ManufacturerChemenu
- Product numberCM325813
- Product description6-tert-butyl-4-hydroxy-pyran-2-one 95+%
- Packaging250mg
- Price$356
- Updated2021-12-16
- Buy
- ManufacturerChemenu
- Product numberCM325813
- Product description6-tert-butyl-4-hydroxy-pyran-2-one 95+%
- Packaging1g
- Price$889
- Updated2021-12-16
- Buy
| Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|
| American Custom Chemicals Corporation | CHM1554885 | 6-TERT-BUTYL-4-HYDROXY-PYRAN-2-ONE 95.00% | 5MG | $455.86 | 2021-12-16 | Buy |
| Chemenu | CM325813 | 6-tert-butyl-4-hydroxy-pyran-2-one 95+% | 100mg | $178 | 2021-12-16 | Buy |
| Chemenu | CM325813 | 6-tert-butyl-4-hydroxy-pyran-2-one 95+% | 250mg | $356 | 2021-12-16 | Buy |
| Chemenu | CM325813 | 6-tert-butyl-4-hydroxy-pyran-2-one 95+% | 1g | $889 | 2021-12-16 | Buy |
Properties
Melting point :131-133 °C
Boiling point :263.0±40.0 °C(Predicted)
Density :1.203±0.06 g/cm3(Predicted)
pka :5.20±0.30(Predicted)
Boiling point :263.0±40.0 °C(Predicted)
Density :1.203±0.06 g/cm3(Predicted)
pka :5.20±0.30(Predicted)
Safety Information
| Symbol(GHS): | ||||||||
|---|---|---|---|---|---|---|---|---|
| Signal word: | ||||||||
| Hazard statements: |
|
|||||||
| Precautionary statements: |
|
